Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Medicaid Budget And Programs topic

No spam. Unsubscribe anytime.

Joint subcommittee approves Medicaid budget package, including drug-rebate changes, rate increases and program expansions

3202453 · May 7, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Joint Subcommittee on Human Services on April 30 approved a package of Medicaid budget adjustments and program changes, voting to accept updated prescription drug rebate projections and to implement a single preferred drug list, approve mandatory and selected discretionary provider rate increases, expand several behavioral-health services and authorize multiple administrative and technical actions to support those changes.

Carson City '025' '025 ' (AP-style)

The Joint Subcommittee on Human Services on April 30 approved a package of Medicaid budget adjustments and program changes, voting to accept updated prescription drug rebate projections and to implement a single preferred drug list, approve mandatory and selected discretionary provider rate increases, expand several behavioral-health services and authorize multiple administrative and technical actions to support those changes. The panel also approved a set of staff and contract resources to strengthen fiscal analysis and audit capacity in Medicaid administration.

Why it matters: The subcommittee's approvals reshape how Nevada projects and uses prescription drug rebate revenue, direct supplementary payments to providers, and funds new or expanded behavioral-health services. Several items change the division's fiscal assumptions that flow into general-fund offsets, special reserves and future work-program authority.

Key decisions and figures

- Prescription drug rebates and single preferred drug list: Fiscal staff described updated rebate revenue projections and recommended two actions: (1) accept an adjusted baseline for projected rebate income and (2) approve a single statewide preferred drug list intended to increase supplemental rebates. The subcommittee approved the governor's package that includes projected incremental rebate revenue of $12.5 million in FY 2026 and $25 million in FY 2027 from the preferred drug list and administrative expenditures of about $3.3 million (including $1.2 million general fund) to stand up vendor support and implementation. The panel also approved a small, recurring contract set-aside (about $756,430 total per year in statewide projections) to hire vendor expertise to improve rebate methodology, with roughly one-third as the state share and the remainder returned to the federal government when applicable. A letter of intent to report vendor progress by Aug. 1, 2026 was discussed as part of implementation.

- State share of rebate revenue and reserve treatment: Staff presented three alternatives to calculate the state share of rebates (22% per the governor; 33.1% based on FY 2024 actuals; or a 27.5% midpoint). The subcommittee chose the 27.5% midpoint approach and directed that half of the resulting annual surplus (about $11.5 million each year by staff estimate) be placed in a one-time special reserve inside the Medicaid account, with the remainder returned to the general fund as savings. Fiscal staff emphasized that any use of reserve funds for programmatic spending would require a work program revision under NRS chapter 353.

- Provider reimbursement rate increases: The subcommittee approved mandatory rate increases and a set of discretionary rate adjustments for selected services. Staff stated the mandatory package (decision unit M101) totals roughly $153.9 million in FY 2026 and $275.4 million in FY 2027 after adjustments, including managed-care inflation and FMAP corrections. The subcommittee approved discretionary increases for several service categories (approved items included home-delivered meals inflation, partial hospitalization, day-treatment and skilled-nursing quality incentives where specified) and rejected certain other discretionary requests per staff recommendations; votes were recorded as motions carried.

- Behavioral health and service expansions: The panel approved expansions and rate changes for several behavioral-health programs funded largely with transfers from the private hospital provider tax (PHPT) account and federal matching dollars. Approved expansions include mobile crisis coverage for youth, assertive community treatment (ACT), first-episode psychosis treatment, expanded adult dental in later amendments, and targeted juvenile-justice health services. The subcommittee approved moving forward with actuarial work and asked the agency to report baseline and utilization analyses to the interim finance committee by Aug. 1, 2026.

- Waiver slot increases and caseload updates: The subcommittee approved adjustments to waiver caseloads and modest slot increases for home- and community-based services (decision totals captured in the closing packet), based on updated March 2025 projections. Members also approved routine caseload updates and several budget amendments that corrected eligibility-category cost-per-eligible and FMAP claiming errors.

- PARIS vendor verification and managed-care prepayment: The Public Assistance Reporting Information System (PARIS) vendor proposal was approved; staff described an analytic match that supported projected disenrollments and recovery of $46.9 million in FY 2026 and $48.2 million in FY 2027 (savings and vendor fees netted as presented). The subcommittee also approved a one-time use of FY 2025 surplus funds to prepay a month of FY 2026 managed-care payments (budget amendment), reducing FY 2026 general-fund need by staff's estimate but using one-time surplus.

- Immigration-policy caseload impacts: The panel adopted the agency's scenario modeling the potential effect of federal immigration policy on Medicaid caseloads, accepting the proposed reductions (approximately $54.5 million in FY 2026 and $89.5 million in FY 2027 in the Medicaid account) subject to the agency operating within legislative appropriation limits if projected savings do not materialize.

- Nevada Health Link automation (eligibility): The subcommittee approved funding to automate Medicaid eligibility determinations through Nevada Health Link, authorizing positions and contract support to move MAGI-based (modified adjusted gross income) determinations to the exchange. Staff and the agency noted uncertainty about downstream staffing impacts to the Division of Welfare and Supportive Services and required a letter of intent for a status report by July 1, 2026 describing implementation progress, ongoing costs and staffing impacts.

- Nevada Health Authority reorganization and administrative positions: The committee approved budget components to support a reorganization that would create a Nevada Health Authority contingent on enabling legislation (BDR 401116 or other). That action included technical adjustments and transfers and the panel separately approved funding for one unclassified deputy director position to support community engagement and workforce development for the proposed authority.

- Positions, audits and contracted fiscal support: The subcommittee approved multiple administrative positions and several targeted contract-funded initiatives intended to strengthen fiscal and actuarial capacity: contract fiscal support ($500,000 general fund per year), a contracted chief economist ($approximately $132,600 GF per year), a contracted administrative services officer (about $144,700 GF per year) and a fiscal audit team (two permanent management-analyst positions plus associated expenditures). The committee emphasized the need for vendor expertise to bolster caseload and revenue projections and to provide pre- and post-audit capability.

- Applied behavior analysis (ABA) rates: The governor had recommended increases required by statute to align ABA rates to comparable-state medicaid rates. The subcommittee voted to NOT recommend approval of the governor's ABA rate increase package as presented; members also voted to sponsor a bill-draft request to amend the relevant statute to repeal an automatic rate-setting requirement (the motion withdrew support for the automatic adjustment and sought statutory clarification).

- Children's specialty managed care plan and letters of intent: The subcommittee approved modest administrative funding for a proposed specialty children's managed-care plan and requested a letter of intent directing the agency to report final rates, program structure and projected costs to the interim finance committee within 30 days after those items are set.

- Graduate medical education (GME): The subcommittee approved an expansion of the existing GME supplemental payment program (decision unit E262) consistent with prior committee action, and did not approve two decision units that would have transferred an $85 million general-fund appropriation into Medicaid to move an existing program without the committee's earlier direction. Instead, the committee followed prior full-committee direction to preserve a grant-account structure and to maintain consistency with earlier actions.

- Public option and trust-account funding: The committee approved continuation-level administrative funding for the public option (general-fund appropriations of $2.4 million per year in the governor's recommendation) and separately approved authority to hire an unclassified manager (funded by federal pass-through when available) plus $250,000 general fund in each year for vendor support. Recorded opposition from several members was noted during votes on the public option items, but the package carried.

- Provider-tax programs, UPL and intergovernmental transfers: The panel approved continued use and technical adjustments for the private hospital provider tax and nursing-facility provider tax programs (PHPT and NFPT), including transfers to Medicaid and checkup accounts to fund supplemental and directed payments. The subcommittee also approved an academic partnership transfer from UNR School of Medicine to fund clinical-advisor positions and continued the Upper Payment Limit (UPL) holding account for the biennium.

Votes and procedure

Most votes were recorded as motions that carried unanimously after staff presentations and brief member questions. Several items recorded individual no votes (notably public-option related motions and the separate public-option manager/vendor-support motion). For items that place surplus general funds into special reserves, the subcommittee required that work-program revisions be filed with the interim finance committee before funds may be spent.

What the subcommittee did not do

- The panel declined to accept the automatic ABA-rate increases as drafted and asked for statutory revision. - The subcommittee did not approve the transfer of the $85 million general-fund appropriation to Medicaid (decision units E500 and E900) to move the graduate medical education grant account without the committee's previously agreed approach.

Looking ahead

The subcommittee mandated multiple letters of intent and follow-up reports (commonly requested to the interim finance committee by summer 2026) to ensure actuarial analyses, vendor progress, implementation timelines and staffing impacts are documented before larger ongoing commitments are finalized in the next biennium. Several approvals were explicitly contingent on enabling legislation (for the Nevada Health Authority) or on future federal approvals (for PHPT, federal pass-through and managed-care waivers).

Ending: The meeting concluded with public comment from an advocacy speaker who urged easier access to medications and protections for Medicaid beneficiaries with severe mental-health needs. The subcommittee adjourned after completing the closing actions.

(Reporting by the committee record and staff presentations; motions and outcomes as recorded in the joint subcommittee hearing record.)